• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

Tecvayli Effective Maintenance Therapy in Newly Diagnosed Multiple Myeloma

by | Dec 9, 2024 | Uncategorized

Source: CureToday articles Tecvayli alone or plus Revlimid has been found to be safe and may result in high MRD-negativity rates. Read More

Darzalex Faspro May Improve Progression, Survival in Smoldering Multiple Myeloma

by | Dec 9, 2024 | Uncategorized

Source: CureToday articles The risk for disease progression or death was reduced by 51% with subcutaneous Darzalex Faspro in certain patients with smoldering multiple myeloma. Read More

Daratumumab superior to active monitoring for high-risk smoldering multiple myeloma

by | Dec 8, 2024 | Uncategorized

SAN DIEGO — Daratumumab monotherapy significantly delayed progression of high-risk smoldering multiple myeloma to active multiple myeloma compared with active monitoring, according to results of the randomized phase 3 AQUILA study.Daratumumab (Darzalex, Janssen)...

D-VRd May Improve Minimal Residual Disease Responses in Multiple Myeloma

by | Dec 8, 2024 | Uncategorized

Source: CureToday articles For patients with transplant-ineligible or -deferred newly diagnosed multiple myeloma, the addition of Darzalex to VRd improved MRD responses as well as progression-free survival. Read More

High-fiber diet may slow progression of precursor conditions to multiple myeloma

by | Dec 7, 2024 | Uncategorized

SAN DIEGO — A high-fiber plant-based diet may delay progression of certain precursor conditions to multiple myeloma, according to study results presented at ASH Annual Meeting and Exposition.The intervention also improved biomarkers of the disease, results of the...

Blenrep Combo Accepted for FDA Review in R/R Multiple Myeloma

by | Dec 3, 2024 | Uncategorized

Source: CureToday articles The FDA has accepted a biologics license application for Blenrep plus bortezomib or pomalidomide for patients with relapsed or refractory multiple myeloma. Read More
« Older Entries
Next Entries »

Recent Content

  • DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy
  • NCCN Flash Update: Changes to Colon Cancer Guidelines, Version 3.2025
  • Commitment to Patients Is Driven by a Lasting Promise
  • AAN 2025: Low-Sodium Oxybate Improves Sleep Quality, Daily Functioning in Narcolepsy, Idiopathic Hypersomnia
  • Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care
  • New Options for ER+ Breast Cancer Spotlighted at Patient Event
  • Asembia’s AXS25 Summit: Must-See Sessions, Expert Interviews as Specialty Pharmacy Gathers
  • A Digital Detox for the Soul with Lynch Syndrome
  • NCPA Urges DOGE to Examine PBMs for Waste, Fraud, and Abuse
  • Decipher Prostate Test Now Available for Metastatic Prostate Cancer
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT